XML 53 R41.htm IDEA: XBRL DOCUMENT v3.20.2
Equity Incentive Plan - Schedule of Stock Option Activity (Details) - 2017 Equity Incentive Plan [Member]
9 Months Ended
Sep. 30, 2020
USD ($)
$ / shares
shares
Directors [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Options, Granted 6,500,000
Non-Qualified Stock Options [Member] | Directors [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Options, Outstanding Beginning 900,000
Number of Options, Granted 6,500,000
Number of Options, Exercised
Number of Options, Forfeited/Cancelled
Number of Options, Expired
Number of Options, Outstanding Ending 7,400,000
Number of Options, Exercisable Ending 6,400,000
Weighted Average Exercise Price, Outstanding Beginning | $ / shares $ 0.135
Weighted Average Exercise Price, Granted | $ / shares 0.057
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Exercise Price, Forfeited | $ / shares
Weighted Average Exercise Price, Expired | $ / shares
Weighted Average Exercise Price, Outstanding Ending | $ / shares 0.067
Weighted Average Exercise Price, Exercisable Ending | $ / shares $ 0.070
Weighted Average Remaining Contractual Term, Outstanding Beginning 7 years 7 months 6 days
Weighted Average Remaining Contractual Term, Granted 8 years 6 months
Weighted Average Remaining Contractual Term, Outstanding Ending 7 years 8 months 12 days
Weighted Average Remaining Contractual Term, Exercisable Ending 8 years
Aggregate Intrinsic Value, Outstanding Beginning | $
Aggregate Intrinsic Value, Outstanding Ending | $
Aggregate Intrinsic Value, Exercisable Ending | $
Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending | $
Employees and Consultants [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Options, Granted 6,616,900
Employees and Consultants [Member] | Non-Qualified Stock Options [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Options, Outstanding Beginning 10,135,000
Number of Options, Granted 6,616,900
Number of Options, Exercised
Number of Options, Forfeited/Cancelled
Number of Options, Expired (2,440,900)
Number of Options, Outstanding Ending 14,311,000
Number of Options, Exercisable Ending 12,311,000
Number of Options, Outstanding vested and Expected to vest Ending 14,311,000
Weighted Average Exercise Price, Outstanding Beginning | $ / shares $ 0.096
Weighted Average Exercise Price, Granted | $ / shares 0.070
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Exercise Price, Forfeited | $ / shares
Weighted Average Exercise Price, Expired | $ / shares 0.100
Weighted Average Exercise Price, Outstanding Ending | $ / shares 0.084
Weighted Average Exercise Price, Exercisable Ending | $ / shares 0.083
Weighted Average Exercise Price, Outstanding vested and Expected to vest Ending | $ / shares $ 0.084
Weighted Average Remaining Contractual Term, Outstanding Beginning 7 years 8 months 12 days
Weighted Average Remaining Contractual Term, Granted 10 years
Weighted Average Remaining Contractual Term, Expired 4 years 4 months 24 days
Weighted Average Remaining Contractual Term, Outstanding Ending 8 years 6 months
Weighted Average Remaining Contractual Term, Exercisable Ending 8 years 6 months
Weighted Average Remaining Contractual Term, Outstanding vested and expected to vest, Ending 8 years 6 months
Aggregate Intrinsic Value, Outstanding Beginning | $
Aggregate Intrinsic Value, Outstanding Ending | $
Aggregate Intrinsic Value, Exercisable Ending | $
Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending | $